Wednesday, July 10, 2013
2:30-4:00 pm
InterAction
1400 16th St., N.W., Suite 210
Washington, D.C. 20036
Call in available: 202-667-8227; ask for the QUAMAD briefing
Please join us on Wednesday, July 10 at 2:30 for a joint presentation on QUAMED and OFDA activities to assure the procurement of safe, effective, quality pharmaceuticals in low income / developing countries.
Christophe Luyckx from QUAMED (www.quamed.org) will discuss the extent and dangers of substandard and counterfeit medicines in developing countries and the measures being implemented to address this health menace. QUAMED is a program of the Institute of Tropical Medicine (Antwerp, Belgium) that seeks to improve access to quality medicines in developing countries by establishing a network of non-profit organizations involved in supplying medicines.
QUAMED members include both humanitarian non-governmental organizations and non-profit procurement centers in developing countries. The QUAMED network currently includes 29 partners in more than 13 countries. These QUAMED members are responsible for providing services to more than 90 million patients all around the world.
Alexandr Kosyak, USAID / OFDA Pharmacist, will present on USAID’s Office of Foreign Disaster Assistance OFDA’s pharmaceutical approval procedures and the pharmaceutical wholesaler pre-qualification program. The discussion will address the need for assuring that only safe, effective, quality pharmaceuticals are purchased from procurement centers (pharmaceutical wholesalers) that conform to GDPs and GSPs.
Participants will gain a better understanding of the problems surrounding the procurement of pharmaceuticals in low income / developing nations and how NGO partners may avoid harming the very beneficiaries they are trying to aid.
Please RSVP to
Danielle Heiberg, dheiberg@interaction.org
IH CONNECT 